• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SSF
Click for more information
0.00% 0.0¢

SMART ABS SERIES 2017-1 TRUST

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SSF
Ann: Full Year Statutory Accounts 		26/07/18 0 96
26/07/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  96 
SSF
Ann: Deed of Amendment 		26/07/17 0 188
26/07/17 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  188 
SSF
Ann: Series Supplement 		26/07/17 0 239
26/07/17 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  239 
SSF
Ann: General Security Deed 		26/07/17 0 216
26/07/17 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  216 
SSF
Ann: Master Security Trust Deed 		26/07/17 0 175
26/07/17 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  175 
SSF
Ann: Master Trust Deed 		26/07/17 0 232
26/07/17 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  232 
SSF
Ann: Information Memorandum 		26/07/17 0 176
26/07/17 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  176 
SSF
Ann: Appendix 1B and Information Form and Checklist 		26/07/17 0 127
26/07/17 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  127 

See All Discussions arrow Created with Sketch.

Top Stories

ACCC seeks Olam divestments before it can buy Namoi Cotton

Australia's market regulator the ACCC has expressed further concerns about the potential takeover of Namoi Cotton by Olam Agri.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
The market's shrugged at China's stimulus measures all year. Why is this one different? If you've been following the Chinese economy this year, you'd know that the country has been trying to stimulate all year.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
The winners & losers on market if negative gearing were gone Removing negative gearing would likely cause a seismic shift in investor behaviour. If that advantage were taken away, more investors might start eyeing the stock market...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.